trending Market Intelligence /marketintelligence/en/news-insights/trending/SlJ9-4tHYk--M9TKzMhQYA2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

William Blair grows biopharma coverage, names co-group heads in equity research

Street Talk Episode 68 - As many investors zig away from bank stocks, 2 vets in the space zag toward them

Street Talk Episode 66 - Community banks tap the debt markets while the getting is good

Street Talk Episode 67 - Veteran investor tabs Mick Mulvaney to help with latest financial stock-focused fund

Street Talk Episode 65 - Deferral practices trap US bank portfolios in purgatory


William Blair grows biopharma coverage, names co-group heads in equity research

William Blair & Co. LLC is expanding biopharmaceuticals coverage in its equity research and institutional sales and trading teams.

In line with the increased focus, the company reorganized its healthcare equity research coverage into two groups: biopharmaceuticals and healthcare technology. It named Tim Lugo and Katherine Xu co-group heads of the biopharmaceuticals equity research team and will promote Andy Hsieh, Matt Phipps and Raju Prasad to senior research analysts. In addition, Amanda Murphy will expand her existing biopharmaceuticals and diagnostic services equity research coverage to include companies focused on gene sequencing and gene editing technologies.

In institutional sales and trading, William Blair promoted John Mullaly to global healthcare coverage specialist.